Distribution of macrolide-resistance genes in Staphylococcus aureus blood-culture isolates from fifteen German university hospitals

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 19, Issue 5, 2000, Pages 385-387

  Schmitz, F J ^a   Petridou, J ^b   Fluit, A C ^a   Hadding, U ^b   Peters, G ^c   Von Eiff, C ^c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; MACROLIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLOOD CULTURE; CONTROLLED STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BLOOD; CULTURE MEDIA; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; GERMANY; HOSPITALS, UNIVERSITY; HUMANS; METHICILLIN; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0034044040     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050500     Document Type: Article

References (13)

1. 1. Weisblum B: Erythromycin resistance by ribosome modification. Antimicrobial Agents and Chemotherapy (1995) 39:577-585
2. 2. Schmitz F-J, Fluit AC: Mechanisms of resistance. In: Armstrong D, Cohen J (eds): Textbook of infectious diseases. Anti-infective therapy, Mosby International, London (1999) Section 7, pp 2.1-2.14
3. 3. Wondrack L, Massa M, Yang BV, Sutcliffe J: Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrobial Agents and Chemotherapy (1996) 40:992-998
4. 4. Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L: Detection of erythromycin-resistant determinants by PCR. Antimicrobial Agents and Chemotherapy (1996) 40:2562-2566
5. 5. Ross JI, Eady EA, Cove JH, Baumberg S: Identification of a chromosomally encoded ABC-transporter system with which the staphylococcal erythromycin exporter MsrA may interact. Gene (1995) 153:93-98
6. 6. Milton ID, Hewitt CL, Harwood CR: Cloning and sequencing of a plasmid-mediated erythromycin resistance determinant from Staphylococcus xylosus. FEMS Microbiology Letters (1992) 97:141-148
7. 7. Von Eiff C, Reinert RR, Peters G for the German M.A.R.S. Study Group: In vitro activity of quinupristin-dalfopristin in comparison to other antibiotics against staphylococci from patients with bacteremia - first results of a German multicentre study. In: Zinner SH, Young LS, Acar JF, Ortiz-Neu C (eds): New considerations for macrolides, azalides, streptogramins, and ketolides. Marcel Dekker, New York (1999) pp 268-274
8. 8. Von Eiff C, Reinert RR, Peters G for the Study Group: Prevalence of antibiotic resistance in staphylococci from patients with bacteremia in German tertiary care hospitals. In: Proceedings of the 9th European Congress of Clinical Microbiology and Infectious Diseases, Berlin, Clinical Microbiology and Infection (1999) Abstract P881, p 321
9. 9. Greisen K, Loeffelholz M, Purohit A, Leong D: PCR-primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid. Journal of Clinical Microbiology (1994) 32:335-351
10. 10. Lina G, Quaglia A, Reverdy M-E, Leclercq R, Vandenesch F, Etienne J: Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrobial Agents and Chemotherapy (1999) 43:1062-1066
11. 11. Westh H, Hougaard DM, Vuust J, Rosdahl VT: Prevalence of erm gene classes in erythromycin-resistant Staphylococcus aureus strains isolated between 1959 and 1988. Antimicrobial Agents and Chemotherapy (1995) 39:369-373
12. 12. Thakker-Varia S, Jensen WD, Moon-McDermott L, Weinstein MP, Dubin DT: Molecular epidemiology of macrolide-lincosamide-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococci. Antimicrobial Agents and Chemotherapy (1987) 31 :735-743
13. 13. Eady EA, Ross JI, Tipper L, Walters CE, Cove JH, Noble WC: Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. Antimicrobial Agents and Chemotherapy (1993) 37:211-217